← Leaderboards
Ali Zarrinpar
University Of Florida
$3,030,032
Attributed
$4,756,519
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $769.8K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,756,519 · 6
By mechanism
R01$2,744,402 · 1
K08$814,011 · 1
UH2$556,111 · 1
R21$363,937 · 1
UH3$152,462 · 1
K24$125,596 · 1
Top collaborators
- Benjamin George Keselowsky7 shared
- Chih-Ming Ho3 shared
Most similar at University Of Florida
Same institution · by research overlap
- Jae-Sung Kim$5,173,690
- Benjamin George Keselowsky$10,555,340
- David R Nelson$45,053,283
- Mark A Atkinson$38,540,675
- Christiaan Leeuwenburgh$12,630,567
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoIn VitroTransplantationOrganNovel TherapeuticsFutureLiverInflammationOperative Surgical ProceduresMetabolicImmuneReperfusion InjuryCellsProgramsImmune ResponseInjuryInflammatoryMyocardial InfarctionTissuesLiver IschemiaCell DeathAcuteOrgan FailureStroke
Grant awards (19)
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$569,158
R01 · FY2025 · DK
Mentoring Patient-Oriented Research in Immune Response in Transplantation$125,596
K24 · FY2025 · AI · contact PI
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$616,580
R01 · FY2024 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$74,969
R01 · FY2024 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$654,230
R01 · FY2023 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$115,581
R01 · FY2023 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$676,374
R01 · FY2022 · DK
Diversity Supplement: Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$37,510
R01 · FY2022 · DK
Ischemia-reperfusion injury in liver transplantation$154,764
K08 · FY2021 · DK · contact PI
Ischemia-reperfusion injury in liver transplantation$38,691
K08 · FY2021 · DK · contact PI
Ischemia-reperfusion injury in liver transplantation$154,764
K08 · FY2020 · DK · contact PI
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$152,462
UH3 · FY2020 · TR · contact PI
Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine$194,156
R21 · FY2019 · DK · contact PI
Ischemia-reperfusion injury in liver transplantation$154,764
K08 · FY2019 · DK · contact PI
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$269,386
UH2 · FY2018 · TR · contact PI
Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine$169,781
R21 · FY2018 · DK · contact PI
Ischemia-reperfusion injury in liver transplantation$154,764
K08 · FY2018 · DK · contact PI
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$286,725
UH2 · FY2017 · TR · contact PI
Ischemia-reperfusion injury in liver transplantation$156,264
K08 · FY2017 · DK · contact PI